Form 4 for VCYT VERACYTE, INC.
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0001649245-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | 2026-02-26 | VCYT | Febbo Phillip G. | Chief Scientific, Med Off | F - Tax | $38.75 | -24.5K | 136.8K | -15% | -$948.8K | |
| 2026-03-02 | 2026-02-26 | VCYT | Febbo Phillip G. | Chief Scientific, Med Off | A - Grant | $0.00 | +71.8K | 161.3K | +80% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-26 | F | D | 24,486 | $38.75 | 136,806 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-26 | A | A | 71,806 | $0.00 | 161,292 | D | — | — |